跳至主要内容
临床试验/CTRI/2022/06/043050
CTRI/2022/06/043050已完成未知

A prospective randomized hepatic safety analysis of subjects used samshamani vati / guduchi ghana vati in prevention of covid-19

JSS Ayurveda College0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • The subjects included in the analysis of irrespective sex in between the age 20 years to 60 years those have no disease. The subjects are Willing to come for regular follow up visits will be included in the study.

排除标准

  • The subjects having severe liver, kidney and heart diseases are excluded in the study. Patients who are currently participating in any other clinical trial. Subject with history of alcohol consumption > than 20 gm/week and/or drug abuse Known allergy, sensitivity or intolerance to the study drugs and their formulation ingredients are excluded in the study. Any condition that in the opinion of the investigator does not justify the patientââ?¬•s inclusion for the study.

研究者

发起方
JSS Ayurveda College

相似试验